You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

BENZYL BENZOATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Benzyl Benzoate, and when can generic versions of Benzyl Benzoate launch?

Benzyl Benzoate is a drug marketed by Lannett and is included in one NDA.

The generic ingredient in BENZYL BENZOATE is benzyl benzoate. There are fifty drug master file entries for this compound. Additional details are available on the benzyl benzoate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for BENZYL BENZOATE?
  • What are the global sales for BENZYL BENZOATE?
  • What is Average Wholesale Price for BENZYL BENZOATE?
Summary for BENZYL BENZOATE
Drug patent expirations by year for BENZYL BENZOATE
Recent Clinical Trials for BENZYL BENZOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
College of Physicians and Surgeons PakistanEARLY_PHASE1
University of AleppoPHASE3
Tishreen University HospitalPHASE3

See all BENZYL BENZOATE clinical trials

US Patents and Regulatory Information for BENZYL BENZOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett BENZYL BENZOATE benzyl benzoate EMULSION;TOPICAL 084535-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Benzyl Benzoate

Last updated: July 29, 2025

Introduction

Benzyl benzoate, a longstanding pharmaceutical and cosmetic ingredient, has sustained relevance due to its therapeutic and industrial applications. Its primary uses—including treatment of scabies and lice, as well as applications in cosmetics and industrial processes—position it within a diverse market landscape. Understanding its market dynamics and financial trajectory is crucial for stakeholders, ranging from pharmaceutical companies to investors. This analysis explores supply-demand factors, competitive environment, regulatory landscape, and future growth prospects driving benzyl benzoate’s market evolution.

Market Overview

Benzyl benzoate is an aromatic ester with potent acaricidal and insecticidal properties. It is widely used in topical formulations to treat parasitic infestations and as a fixative in perfumes and cosmetics. Additionally, benzyl benzoate's solvent properties extend its industrial utility.

The global market is segmented primarily into pharmaceutical, cosmetic, and industrial applications, each impacting demand patterns distinctly. The compound’s approval status across regulations in different regions influences its market stability and growth potential.

Demand Drivers

Pharmaceutical Segment

The dominant application of benzyl benzoate stems from its efficacy as a topical agent against scabies and lice. Globally, increasing prevalence of parasitic infestations and rising awareness about dermatological treatments drive steady demand. According to WHO reports, over 200 million people worldwide suffer from scabies, fueling consistent demand for effective therapeutic agents [1].

Moreover, benzyl benzoate’s status as a low-cost, effective remedy in developing countries enhances its market accessibility. Its usage extends into pediatric and adult formulations, securing broad demographic coverage, which continues to support consistent sales growth.

Cosmetic and Personal Care Industry

In the cosmetics market, benzyl benzoate functions as a fragrance fixative and solvent, contributing to its stability and longevity in perfumes and skincare products. The rising global cosmetic expenditure, particularly in emerging economies such as China and India, fosters upward demand.

Industrial Applications

Industrial uses, mainly as a solvent and plasticizer, alternate its demand streams. The chemical's high purity and stability make it suitable for various manufacturing processes, including the production of dyes, plastics, and electronics. Growth in these industrial sectors indirectly influences benzyl benzoate’s market trajectory.

Market Dynamics

Supply Chain and Production

Benzyl benzoate is primarily synthesized through esterification of benzoyl chloride and benzyl alcohol or via transesterification processes. Key chemical producers in China, India, and the United States dominate supply. Price fluctuations typically follow raw material availability, environmental regulations, and geopolitical factors.

Over the past decade, the expansion of manufacturing capacities in Asia has resulted in supply surplus, exerting downward pressure on prices. However, stringent environmental regulations in certain regions have occasionally constrained production, influencing availability and pricing.

Regulatory Landscape

The regulatory environment impacts market stability. Benzyl benzoate is approved by entities like the FDA and EMA for therapeutic use in topical dermatological formulations, with some restrictions on concentration levels. Regulatory divergence across regions influences market entry and product formulation strategies.

Notably, safety concerns associated with allergic reactions and skin irritation limit its concentration in certain applications, encouraging formulation innovations for safety enhancement, which can influence pricing and market share.

Competition and Substitutes

While benzyl benzoate remains a cost-effective primary choice for scabies and lice treatments, alternatives like permethrin, ivermectin, and malathion exert competitive pressure. These alternatives often offer improved safety profiles but come with higher costs.

The market’s competitive landscape is characterized by ongoing R&D to develop novel compounds with enhanced efficacy and safety. However, benzyl benzoate’s low-cost profile ensures its continued dominance, especially in resource-constrained markets.

Market Challenges

  • Safety Concerns: Potential for allergic dermatitis and skin irritation limits its concentration and usage spectrum.
  • Regulatory Constraints: Increasing restrictions on cosmetic and pharmaceutical-grade benzyl benzoate hamper some applications.
  • Environmental Impact: Waste disposal and manufacturing emissions pose environmental challenges, prompting regulatory modifications.

Financial Trajectory

Historical Trends

Over the last decade, the global benzyl benzoate market has displayed steady growth, with an estimated Compound Annual Growth Rate (CAGR) of approximately 4-6% driven by pharmaceutical demand and expanding industrial applications [2].

Pricing has experienced moderate volatility linked to raw material costs and regional regulations. The pharmaceutical sector remains the largest revenue contributor, maintaining stable demand amid competitive pricing strategies.

Forecast and Future Outlook

The market outlook remains optimistic, with projected CAGR of 5-7% over the next five years. Several factors influence this trajectory:

  • Growth in Parasitic Disease Treatment: Increased healthcare access in LMICs sustains demand.
  • Cosmetic Expansion: The booming beauty industry in Asia and South America contributes to regional growth.
  • Innovation and Formulation: New formulations with improved safety profiles bolster product longevity in markets with regulatory concerns.
  • Industrial Expansion: Growth in manufacturing sectors, particularly in Asia, supports steady industrial demand.

Potential headwinds include regulatory tightening and substitution by newer, safer compounds. Nonetheless, benzyl benzoate’s cost-effectiveness and established efficacy position it favorably within the global market.

Revenue Forecast

Based on current trends, annual revenues from benzyl benzoate are forecasted to increase from an estimated $300-350 million in 2022 to over $500 million by 2027. The pharmaceutical segment will continue to dominate, accounting for roughly 60-65% of total sales. The cosmetic sector is poised for accelerated growth, aligned with expanding consumer markets and product innovations.

Strategic Implications

Companies operating in this space should prioritize:

  • Fostering Innovation: Developing formulations that mitigate safety concerns can extend market share.
  • Global Expansion: Targeting emerging markets with rising parasitic disease prevalence expands revenue streams.
  • Regulatory Compliance: Staying ahead of regulatory changes ensures uninterrupted market access.
  • Supply Chain Optimization: Diversifying sourcing and manufacturing regions minimizes risks associated with geopolitical and environmental disruptions.

Conclusion

Benzyl benzoate’s market dynamics are driven by persistent demand in pediatric and dermatological treatments, coupled with expanding cosmetic and industrial usage. Despite challenges such as safety concerns and regulatory restrictions, its cost-effectiveness and efficacy sustain its market position. The financial trajectory indicates steady growth, with opportunities largely in emerging markets, product innovation, and industrial applications.

As the global healthcare infrastructure continues to evolve and consumer markets expand, benzyl benzoate remains a relevant and economically significant chemical entity. Strategic focus on safety, regulatory adherence, and supply chain resilience will be crucial for stakeholders aiming to capitalize on its growth potential.

Key Takeaways

  • Steady Demand: Benzyl benzoate's primary use in treating scabies and lice ensures consistent global demand, particularly in developing nations.
  • Market Growth: Projected CAGR of approximately 5-7% through 2027, driven by pharmaceutical, cosmetic, and industrial sectors.
  • Price Dynamics: Supply surplus from Asian manufacturers and raw material costs influence pricing; innovation can mitigate safety-related restrictions.
  • Competitive Landscape: Alternatives force continuous innovation, but benzyl benzoate’s affordability maintains its market share.
  • Regulatory Challenges: Increasing safety restrictions require adaptation in formulation and marketing strategies.

FAQs

  1. What are the main medical indications for benzyl benzoate?
    Benzyl benzoate is primarily used in topical treatments for scabies and pediculosis (lice infestations), owing to its acaricidal and pediculicidal properties.

  2. How does the regulatory environment affect benzyl benzoate sales?
    Regulatory authorities impose restrictions on concentration and usage to ensure safety, which can limit formulations and regional market access. Compliance is critical for sustained sales.

  3. Are there any environmental concerns associated with benzyl benzoate?
    Yes. Manufacturing and disposal raise environmental issues, prompting stricter environmental regulations that could influence production costs and availability.

  4. What are key growth regions for benzyl benzoate?
    Developing economies in Asia, particularly China and India, represent significant growth due to rising healthcare infrastructure, parasitic disease prevalence, and expanding cosmetic markets.

  5. What competitive advantages does benzyl benzoate retain over substitutes?
    Its low cost, proven efficacy, and broad applications sustain its market share despite competition from newer pharmaceuticals or chemical alternatives.


Sources
[1] World Health Organization. "Scabies and Pediculosis Management," 2022.
[2] MarketWatch. "Global Benzyl Benzoate Market Forecast," 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.